Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-23

Clinical Trial Update: Lemborexant to Prevent Post-operative Delirium in Cardiac Surgery Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating whether lemborexant can prevent postoperative delirium in patients undergoing cardiac surgery; the study status is not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lemborexant (lemborexant)

Snippet

Sponsor: University of British Columbia | Conditions: Delirium - Postoperative, Cardiac Surgery | Phase 2 | Status: NOT_YET_RECRUITING